But for those families struggling financially, whose savings have already been depleted by the illness, this is a different story.
Two thousand yuan could probably support their family for several months.
The research and development cost of Su Chen's drug is essentially zero.
He relied on his past life experience and advanced medical knowledge.
In short, it's simply a matter of replicating the drug formulations in the laboratory.
Therefore, the real costs are only the procurement of raw materials, the production line manufacturing, and subsidies for clinical trial participants.
There is no longer the research and development cost of hundreds of millions of yuan.
The cost of the medicine, when spread across each box, is only a few cents.
Moreover, as time went on, more and more medicines were produced.
Large-scale centralized production will further reduce costs.
This is also Su Chen's original intention in daring to price each box at 60 yuan.
Over the next few days, orders for the medicine steadily increased.
In just half a month, the number of orders for Recombinant Human exceeded five million boxes.
Even at a price of 60 yuan per box, sales reached a staggering 300 million yuan in an instant!
Of this 300 million yuan, after deducting 10% to 20% of the operating profit from pharmaceuticals, the rest is all gross profit for the company.
Su Chen and Zhou Ting did a quick calculation and found that these orders alone earned them a net profit of 230 million yuan.
They had originally planned to invest tens of millions of yuan in advertising to promote the drug's market launch.
But now, it's completely unnecessary.
Unfortunately, Recombinant Human simply can't keep up with production...
Continue read on readnovelmtl.com
